Abstract:Objectives Transforming growth factor-β1 (TGF-β1) is one of the key mediators of the peritoneal fibrosis. Short hairpin RNAs (shRNA) transcribed by vectors contained U6 or H1 promoter can trigger sequenceselective gene silencing in mammalian cells. This study investigated the effects of shRNA targeting TGF-β1 on the expression of TGF-β1 and ultrastructure in human peritoneal mesohelial cells (HPMCs) induced by peritoneal dialysis solution (PD solution). Methods All tests were performed on the human peritoneal mesothelial cell (HMrSV5). TGF- β1 specific shRNA expression vectors were constructed and introduced to HPMCs stimulated with two commercially available PD solution (1.50% and 4.25% Dianeal) or DMEM to 48h. The dialysis solutions were diluted twofold with DMEM. Expression of TGF-β1 mRNA was detected by semiquantitative reverse transcription polymerase chain reaction (RT-PCR). The TGF-β1 protein level in the culture supernatant was analyzed by enzyme-linked immunosorbent assay. Ultrastructure changes of HPMCs were observed by transmission electron microscopy. Results The expression of TGF-β1 was upregulated significantly in HPMCs stimulated with 4.25% PD solution (P 0.01). TGF-β1 expression in pcDU6 plasmid vector-mediated shRNA group were obviously downregulated when compared to the 4.25% PD solution group and the pcDU6 void vector group (P 0.01), with no significant difference among pcDU6 plasmid vector-mediated shRNA groups (P 0.01). Ultrastructural studies of HPMCs exposed to 4.25% PD solution showed cell flattening, reduced microvilli, and intracellular organelles compatible with dysfunctional mitochondria. In contrast, the ultrastructural morphology of HPMCs was relatively preserved after introduction with TGF-β1 shRNA vectors. Conclusions TGF-β1 specific shRNA can significantly inhibit the expresson of TGF-β1 and ameliorates the ultrastructural abnormalities in HPMCs stimulated with 4.25% PD solution. Our results of this in vitro study suggest that TGF- β1 specific shRNA expression vectors transfer might be of the therapeutic benefit in peritoneal fibrosis. However,further studies in vivo are needed to confirm this hypothesis.

The Effect of Tanshinone ⅡA on the Secretion and Expression of VEGF and TGF-β1 in Cultured Human Peritoneal Mesothelial Cells

Effects of tanshinoneⅡA on oxidative stress and apoptosis cytokine expression of human peritoneal mesothelial cells

Effects of Short Hairpin RNAs on TGF-β1 Expression and Ultrastructure in HPMCs Induced by Peritoneal Dialysis Solution

Effects of Tanshinone IIA on Oxidative Stress and Apoptosis-Related Cytokine Expressions of Human Peritoneal Mesothelial Cells

Effects of Tanshinone Ⅱ A on MMP-2 and TIMP-1 in Continuous Ambulatory Peritoneal Dialysis Patients

Tanshinone IIA Mitigates Peritoneal Fibrosis by Inhibiting EMT Via Regulation of TGF-β/smad Pathway

Astragalus Mongholicus Altered the Secretion and Expression of Transforming Growth Factor-Β1 and Basic Fibroblast Growth Factor in Cultured Human Peritoneal Mesothelial Cells

Protective Effects of Tanshinone IIA on Endothelial Progenitor Cells Injured by Tumor Necrosis Factor-Α

The preventive intervention of tanshinone ⅡA on peritoneal fibrosis in a peritoneal dialysis rat model

Effects of Astragalus on Secretion and Mrna Expression of TGF-β1 Induced by Peritoneal Dialysis Solution in Cultured Human Peritoneal Mesothelial Cell

Tanshinone IIA Attenuates Peritoneal Fibrosis Through Inhibition of Fibrogenic Growth Factors Expression in Peritoneum in a Peritoneal Dialysis Rat Model

[The Effect of Lactate-Buffered Peritoneal Dialysis Fluid in Human Peritoneal Mesothelial Cells Function].

Effect of TGF-β1 on Connective Tissue Growth Factor of Human Peritoneal Mesothelial Cells

[Effect of Tanshinone II A on Expression of EGF and EGFR in Hepatocellular Carcinoma Cell Line SMMC-7721].

Sulfotanshinone ⅡA Sodium Ameliorates Lipopolysaccharide-Peritoneal Dialysis Solution-Elicited Human Peritoneal Mesothelial Cells Injury

Inhibition Effect Of Small Interfering Rna Of Connective Tissue Growth Factor On The Expression Of Vascular Endothelial Growth Factor And Connective Tissue Growth Factor In Cultured Human Peritoneal Mesothelial Cells

The Affects of Tanshinone ⅡA on the Changes of Morphology of Peritoneal Membranes and Oxidative Stress Status in Rat

[Effect of TGFbeta1 Antisense RNA Expression Vector on Synthesis and Secretion of Extracellular Matrix in Cultured Human Peritoneal Mesothelial Cells].

Puerarin protects the cultured human peritoneal mesothelial cells from the damage caused by peritoneal dialysate

Effects of Tanshinone IIA on the Expressions of Angiopoietin-2 and Tie-2 in Human Hepatocellular Carcinoma Cell Line SMMC-7721

Effect of Pentoxifylline on Human Peritoneal Mesothelial Cells' Function and TGF-β1, FN Secretion Induced by Lactate-buffered Peritoneal Dialysis Solutes